Veru Inc. (VERU): Price and Financial Metrics

Veru Inc. (VERU): $0.71

0.03 (-4.67%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

VERU Price/Volume Stats

Current price $0.71 52-week high $1.92
Prev. close $0.74 52-week low $0.36
Day low $0.71 Volume 50,368
Day high $0.74 Avg. volume 1,596,501
50-day MA $0.76 Dividend yield N/A
200-day MA $0.90 Market Cap 103.93M

VERU Stock Price Chart Interactive Chart >


Veru Inc. (VERU) Company Bio


Veru Inc. operates as a urology and oncology biopharmaceutical company. The company operates through two segments, Commercial; and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation. The company's urology drug candidates include Tamsulosin delayed release sachet and Tamsulosin XR capsules that are under bioequivalence study for the treatment of benign prostatic hyperplasia; and Solifenacin delayed release granules, which are under bioequivalence study for the treatment of overactive bladder. Its urology drug candidates also comprise Tadalafil-Finasteride combination capsules that are under bioequivalence study for the treatment of men with lower urinary tract symptoms and enlarged prostate; VERU-944, which is in Phase II clinical trial for the treatment of hot flashes in men on prostate cancer hormonal therapies; and VERU-722 that is in Phase II clinical trial for the treatment of male infertility caused by testicular dysfunction. The company's oncology drug candidate is VERU-111, a novel oral alpha and beta tubulin inhibitor, which is under preclinical study for the treatment of metastatic prostate, breast, endometrial, ovarian, and other cancers. It also develops VERU-111/VERU-112, a novel oral agent targeting colchicine binding site that is under preclinical study for the treatment of gout and familial mediterranean fever. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was founded in 1896 and is based in Miami, Florida.


VERU Latest News Stream


Event/Time News Detail
Loading, please wait...

VERU Latest Social Stream


Loading social stream, please wait...

View Full VERU Social Stream

VERU Price Returns

1-mo 15.37%
3-mo -14.05%
6-mo -12.70%
1-year -5.72%
3-year -88.05%
5-year -70.54%
YTD -1.39%
2023 -86.36%
2022 -10.36%
2021 -31.91%
2020 158.21%
2019 139.29%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!